Mast Therapeutics (MSTX) – Analyst PT Change
-
Mast Therapeutics (MSTX) PT Trimmed at Piper Jaffray But Still Sees a Double
-
Mast Therapeutics (MSTX) PT Raised at Piper Jaffray Following Sickle Cell Conference; Sees 100% Upside
Back to MSTX Stock Lookup